ScholarWorks@Gyeongsang National University

British Journal of Haematology

Journal Title

  • British Journal of Haematology

ISSN

  • E 1365-2141 | P 0007-1048

Publisher

  • Blackwell Publishing Inc.

Listed on(Coverage)

JCR 1997-2019
SJR 1999-2019
CiteScore 2011-2019
SCI 2010-2019
SCIE 2010-2021
CC 2016-2021
SCOPUS 2017-2020
MEDLINE 2016-2021
EMBASE 2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • USA

Aime & Scopes

  • The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Homepage

Article List

1 - 2 out of 2 results.

SCIESCOPUS
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)

Jung, Sung-Hoon; Kim, Dajung; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won Sik; Lee, Ji Hyun; Lee, Gyeong Won; Kim, Min Kyoung, et al.

ArticleIssue Date2025CitationBritish Journal of HaematologyPublisherBlackwell Publishing Inc.
SCIESCOPUS
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

Shin, Junghoon; Lee, Ji Yun; Lee, Gyeong-Won; Kim, Won Seog; Park, Yong; Do, Young Rok; Kim, Dae Sik; Kim, Ki Hwan; Choi, Yoon Seok; Byun, Ja Min, et al.

ArticleIssue Date2023CitationBritish Journal of Haematology, v.202, no.6, pp e54 - e57PublisherBlackwell Publishing Inc.
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어